Table 2.
Test Number | CDI Prevalence | Positive n | Negative n | False Positive n (%) | PPV | NPV |
---|---|---|---|---|---|---|
Sensitivity = 90.3%, Specificity = 96.2% | ||||||
First | 14.9% | 1,669 | 8,331 | 323 (19.4) | 80.6% | 98.3% |
Second | 1.7% | 181 | 3,232 | 127 (70.2) | 29.6% | 99.8% |
Third | 0.2% | 68 | 1,719 | 65 (95.6) | 4.1% | 100.0% |
Sensitivity = 75%, Specificity = 96.2% | ||||||
First | 14.9% | 1,441 | 8559 | 323 (22.4) | 77.6% | 95.6% |
Second | 4.4% | 242 | 3265 | 127 (52.5) | 47.3% | 98.8% |
Third | 1.2% | 80 | 1655 | 65 (81.3) | 18.9% | 99.7% |
Sensitivity = 90.3%, Specificity = 95.0% | ||||||
First | 14.9% | 1,771 | 8,229 | 426 (24.1) | 76.0% | 98.2% |
Second | 1.8% | 219 | 3,371 | 166 (75.8) | 24.4% | 99.8% |
Third | 0.2% | 87 | 1,676 | 84 (97.7) | 3.2% | 100.0% |
|
CDI = C. difficile infection, PPV = positive predictive value, NPV = negative predictive value